Skip to main content

Reactor Production of Thoruim-229...

Publication Type
Journal Name
Applied Radiation and Isotopes
Publication Date
Page Numbers
19 to 27
Aug 2016

Limited availability of 229Th for clinical applications of 213Bi necessitates investigation of alternative production routes. In reactor production, 229Th is produced from neutron transmutation of 226Ra, 228Ra, 227Ac and 228Th. We evaluate irradiations of 226Ra, 228Ra, and 227Ac targets at the ORNL High Flux Isotope Reactor. Yields of 229Th at 25 days are 2.0 ± 0.2 mCi/g, 32.3 ± 1.3 mCi/g, and 7.0 ± 0.3 mCi/g, for 226Ra, 227Ac, and 228Ra respectively. Intermediate radionuclide yields and cross-sections are also studied.